Global Drug-Device Combination Market By Product (Infusion Pumps, Orthopedic Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Balloon, Drug Eluting Stents, Drug Eluting Beads, Antibiotic-Loaded Bone Cements, Glass Ionomer Cements, Nebulizer, Inhaler, Bone Graft Substitutes, Antibacterial-Releasing Dental Restorative Materials, Wound Care Products, Prefilled Syringe, Antimicrobial Catheters, Others), Application (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer Treatment, Antimicrobial Application, Others), End Users (Hospitals, Clinics, ASCs, Medical Laboratories, Home Care, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Industry Trends and Forecast to 2027
Market Analysis and Insights of Drug-Device Combination
Drug-device combination market is analysed by Data Bridge Market Research, wherein we have accounted for the market to witness a potential growth rate of 7.43% in the forecasted period of 2020 to 2027, resulting in the market reaching a cap of USD 198.57 billion by the end of the forecasted period. Increasing growth witnessed across the chronic disease prevalence which have been caused due to the rising volume of geriatric population, these trends are acting as the major driving factors for the drug-device combination market in the above-mentioned forecasted period of 2020 to 2027.
Drug-device combination are described as the medical devices that provide a combination of drug and medical devices to provide advanced therapeutic, diagnostic and other forms of healthcare services in a more effective manner. These combination products enable greater safety, recovery period, and successful rate caused by the added advantage of drug and device combination.
Increasing adoption of home based healthcare services along with growth witnessed across the target population base for these healthcare products and services, these factors in combination are expected to be the major driving factors for drug-device combination market. Various innovations and technological advancements across the major product offerings along with the positive backing of governments and authorities to promote innovations in the healthcare market are expected to be the major drivers of the market in the above-mentioned forecasted period.
Strict regulatory compliances in development and commercialization of these products, amid recent incidences of product, recalls due to product failures and errors in operations, these factors are expected to act as the restraints for market growth in drug-device combination market. Large-scale product costs along with the various complications in operations of these products are also hampering the market growth in the above mentioned forecasted period of 2020 to 2027.
This drug-device combination market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research drug-device combination market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Drug-Device Combination Market Scope and Market Size
Drug-Device Combination market is segmented on the basis of product, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on product, the drug-device combination market is segmented into infusion pumps, orthopedic combination products, photodynamic therapy devices, transdermal patches, drug eluting balloon, drug eluting stents, drug eluting beads, antibiotic-loaded bone cements, glass ionomer cements, nebulizer, inhaler, bone graft substitutes, antibacterial-releasing dental restorative materials, wound care products, prefilled syringe, antimicrobial catheters and others. Infusion pumps segment is further sub-segmented into implantable, insulin, patient-controlled analgesia pump, volumetric, disposables, syringes and ambulatory. Transdermal patches segment is further sub-segmented into passive and active systems. Drug eluting balloon segment is further sub-segmented into coronary drug-eluting balloon and peripheral drug-eluting balloon. Drug eluting stents segment is sub-segmented into coronary drug eluting stents and peripheral drug eluting stents. Nebulizer segment is sub-segmented into ultrasonic, compressor and mesh. Inhaler segment is further sub-segmented into drug powder inhaler (DPI), metered dose inhaler (MDI) and soft mist inhaler (SMI). Prefilled syringe segment is further sub-segmented into single-chamber prefilled syringe, dual-chamber prefilled syringe and customized prefilled syringe. Antimicrobial catheters segment is sub-segmented into urological, cardiovascular and other.
On the basis of application, the drug-device combination market is segmented as cardiovascular diseases, diabetes, respiratory diseases, cancer treatment, antimicrobial application and others. Others segment consists of neurological, skin treatments and others.
Drug-device combination market has also been segmented into hospitals, clinics, ambulatory surgical centers (ASCs), medical laboratories, home care and others on the basis of end user.
Drug-Device Combination Market Country Level Analysis
Drug-device combination market is analysed and market size insights and trends are provided by country, product, application and end users as referenced above.
The countries covered in drug-device combination market report are U.S., Canada and Mexico in North America, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Brazil, Argentina and Rest of South America as part of South America South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa (MEA) as a part of Middle East and Africa (MEA).
North America was the largest share holder for drug-device combination market backed by the availability of favourable reimbursement policies, advanced healthcare infrastructure availability, as well as the growth of patient awareness regarding the benefits of using these medical products. Asia-Pacific will witness growth at the highest rate as the need for improving the existing healthcare services and improvements in disposable income resulting in enhanced affordability of these combination products for the population existing in the region.
The country section of the drug-device combination market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Drug-device combination market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug-device combination market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug-device combination market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Drug-Device Combination Market Share Analysis
Drug-device combination market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug-device combination market.
The major players covered in the drug-device combination market report are Medtronic, Sanofi, Smith & Nephew, Boston Scientific Corporation, BD, Johnson & Johnson Services, Inc., Baxter, Bausch Health, Stryker, 3M, W. L. Gore & Associates, Inc., Terumo Corporation, Pinnacle Biologics, Inc., Cook, Zimmer Biomet, Teleflex Incorporated among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), South America and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Drug-Device Combination Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.